Vyome announced completion of patient enrollment for Proof of Concept Study for VB 1953 for treatmen...View More
Vyome announced top-line data from its phase 1 clinical trial evaluating VB-1953, a topically admini...View More
Co-Founder & CEO of Vyome Biosciences N. Venkat talks to Economic Times about how Vyome is developin...View More
Copyright © 2015 Vyome Biosciences. All rights reserved.